Related Experiment Video
Updated: Dec 4, 2025
10:16
Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
Published on: August 17, 2022
3.6K
Self-amplifying RNA vaccines for infectious diseases
Kristie Bloom1, Fiona van den Berg2, Patrick Arbuthnot2
1Wits/SAMRC Antiviral Gene Therapy Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Private Bag 3, WITS, Johannesburg, 2050, South Africa. Kristie.bloom@wits.ac.za.
Gene Therapy
|October 23, 2020
Summary
Synthetic RNA vaccines offer rapid, scalable manufacturing for faster responses to disease outbreaks. Self-amplifying RNA vaccines show promise for improved immunization against infectious diseases.
Area of Science:
- Vaccinology
- Molecular Biology
- Immunology
Background:
- Vaccinology is increasingly adopting synthetic RNA platforms for vaccine development.
- RNA vaccines offer rapid, scalable, and cell-free manufacturing capabilities.
- The SARS-CoV-2 pandemic highlighted the potential of RNA vaccine candidates.
Purpose of the Study:
- To explore self-amplifying RNAs (saRNAs) as vaccine candidates for infectious diseases.
- To discuss the advantages of synthetic manufacturing approaches for RNA vaccines.
- To assess the potential of saRNAs in preventing and treating chronic infections.
Main Methods:
- Review of preclinical studies on conventional and self-amplifying RNA vaccines.
- Analysis of in vitro transcription and formulation processes for synthetic RNA.
- Comparative assessment of antigen expression between conventional mRNA and saRNA.
Main Results:
- Both conventional and saRNAs have demonstrated protective immunization in preclinical studies.
- saRNAs exhibit enhanced antigen expression at lower doses compared to conventional mRNA.
- saRNA technology shows potential for improved immunization efficacy.
Conclusions:
- Self-amplifying RNAs are emerging as significant vaccine candidates for infectious diseases.
- Synthetic manufacturing provides a rapid and scalable pipeline for vaccine production.
- RNA vaccine technology holds promise for both prophylaxis and treatment of infections.
Related Concept Videos
01:29Viruses with RNA Genomes
502
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
502
01:29Microorganisms in Medicine and Therapeutics
735
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
735
02:15Experimental RNAi
7.0K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.0K
01:03Rous Sarcoma Virus (RSV) and Cancer
5.9K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.9K
02:28Leaky Scanning
5.5K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.5K
02:30siRNA - Small Interfering RNAs
17.9K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.9K